Core Viewpoint - Zhongyuan Inner配 announced a strategic cooperation agreement with Ningbo Puzhi Future Robotics Co., Ltd. regarding humanoid robot-related business [1] Group 1: Strategic Cooperation - The agreement aims for Zhongyuan Inner配's subsidiary, Zhongyuan Inner配 (Shanghai) Electronic Technology Co., Ltd., to become a core supplier of joint modules for humanoid robots produced by Ningbo Puzhi [1] - The Shanghai subsidiary will prioritize the deployment of humanoid robot bodies produced by Ningbo Puzhi in relevant business scenarios [1] Group 2: Financial Impact - The cooperation agreement is a framework agreement, with specific cooperation details to be defined in subsequent project contracts [1] - The expected impact on the company's financial status and operating results for the year 2025 is not anticipated to be significant [1]

Group 1 - Sichuan Chengyu's wholly-owned subsidiary plans to acquire 85% equity of Hubei Jingyi Company for 2.409 billion yuan, enhancing the company's control over highway projects [1] - Huadian Technology signed contracts worth approximately 815 million yuan with Huadian Technology Group for a wind power hydrogen production project [2] - Dongfang Cable and its subsidiary won projects totaling approximately 3.125 billion yuan, accounting for 34.37% of the company's audited revenue for 2024 [3] Group 2 - Heng Rui Medicine received approval for clinical trials of SHR-2906 injection, a self-developed biopharmaceutical aimed at weight control and metabolic regulation [4] - Qingdao Port plans to invest approximately 15.7 billion yuan in two terminal projects [5] - Jingu Co. received a notification to supply low-carbon wheels for two export models to a major domestic car manufacturer, with production expected in 2026 [6] Group 3 - ST Xingguang won a procurement project worth approximately 22.955 million yuan, accounting for 11.96% of the company's revenue for 2024 [7] - Xinbo Co. plans to jointly invest in an alloy materials research institute with partners, focusing on high-performance materials for various industries [8] - Tianqi Lithium's third-phase lithium concentrate expansion project has been completed and is undergoing trial production, with a total capacity of 2.14 million tons per year [9] Group 4 - Changfei Fiber reported that new fiber optic products related to data centers represent a small proportion of total demand [10] - Dongfang Bio's subsidiaries obtained multiple medical device registration certificates, including various testing kits [11] - Xiugang Co. plans to use up to 500 million yuan of idle fundraising for cash management in safe, liquid investment products [12] Group 5 - Jifeng Co. received a project designation for passenger car seat assemblies from a European luxury brand, with a total lifecycle value of approximately 9.8 billion yuan [13] - CanSino initiated Phase I clinical trials for a combined vaccine, completing the first subject enrollment [14] - Dayu Water-saving's subsidiary pre-won a drainage project worth 140 million yuan and another project worth 1 billion yuan [15] Group 6 - Yutong Pharmaceutical's subsidiary received clinical trial approval for YKYY032 injection for treating hyperlipoproteinemia [17] - Diweier announced the departure of a core technical personnel, impacting its technical leadership [18] - Weilang Co.'s controlling shareholder received regulatory measures from the Shandong Securities Regulatory Bureau for failing to fulfill a commitment [19] Group 7 - Xiehe Electronics invested 5 million yuan in a private equity fund focusing on hard technology sectors [20] - Phoenix Optical received a government subsidy of 4.7053 million yuan, representing 35% of its projected net profit for 2024 [21] - China State Construction reported a 0.9% year-on-year increase in new contracts signed in the first 11 months of 2025, totaling 4.0408 trillion yuan [22] Group 8 - Nanguang Energy's pumped storage power station units 1 and 2 have entered trial operation, with units 3 and 4 expected to follow by year-end [23] - Jindalai plans to invest 280 million yuan to acquire a 34% stake in Yunnan Jici Medical Technology [24] - Geer Software terminated its planned acquisition of a majority stake in Weipin Zhiyuan due to failure to reach agreement on key terms [25] Group 9 - Ningbo Fubang completed the absorption merger of its wholly-owned subsidiary, inheriting all assets and liabilities [26] - Zhongyuan Neipei signed a strategic cooperation framework agreement with Ningbo Puzhi Company for humanoid robot-related business [28] - Gongyuan Co. announced a business integration and relocation of its production lines in the East China region [29] Group 10 - Chlor-alkali Chemical's subsidiary plans to invest 2.975 billion yuan in a comprehensive utilization project for waste salt [30] - Kain Technology announced the departure of a core technical personnel, impacting its research capabilities [31] - ST Renfu received approval for clinical trials of a new drug for idiopathic pulmonary fibrosis [32] Group 11 - Sanbo Brain Science's established brain science fund has completed registration with the Asset Management Association of China [33] - Tongyou Technology plans to apply for a 70 million yuan credit line from Beijing Bank, using its property as collateral [34] - Bai Ao Intelligent signed a significant equipment sales contract worth approximately 27.5021 million yuan [35] Group 12 - ST Xinyan received all restructuring investment funds totaling 2.239 billion yuan, entering the execution phase of its restructuring plan [36] - Dalu Real Estate's subsidiary decided to terminate a planned acquisition of a 60% stake in Beijing Chengzhu Real Estate [38] - Huiyu Pharmaceutical's products received marketing approval in Italy and Norway [39]

Core Viewpoint - Zhongyuan Neipei (002448) has signed a strategic cooperation framework agreement with Ningbo Puzhi Future Robotics Co., Ltd. to collaborate on humanoid robot-related businesses [1] Group 1: Company Overview - Zhongyuan Neipei (Shanghai) Electronic Technology Co., Ltd., a subsidiary of Zhongyuan Neipei holding 71.30%, specializes in automotive electronic components, automotive electronic control systems, automotive instruments, and vehicle networking technology [1] - Ningbo Puzhi Company, established by Junsheng Group's Ningbo Junpu Artificial Intelligence and Humanoid Robot Research Institute and Shanghai Zhiyuan New Technology Co., Ltd., focuses on the application of general-purpose robots in smart manufacturing [1] Group 2: Cooperation Details - After the qualification review by Ningbo Puzhi Company, Zhongyuan Neipei (Shanghai) Electronic Technology Co., Ltd. will become the core supplier of humanoid robot joint modules, supplying qualified products as agreed [2] - The collaboration aims to promote the large-scale application and innovation of humanoid robots in industrial and commercial scenarios [2] Group 3: Strategic Implications - Zhongyuan Neipei (Shanghai) Electronic Technology Co., Ltd. has a leading market share in automotive electronic actuators, leveraging its core advantages of small size, light weight, fast response, and high integration [2] - The joint development of specialized electronic control actuators for humanoid robot joints will facilitate the transfer of existing electronic control system technology to the robotics field, aligning with industry technological iteration trends [2][3] - The cooperation is seen as a key initiative for Zhongyuan Neipei to achieve breakthroughs in emerging sectors while maintaining steady growth in its core business [3]

Core Viewpoint - Zhongyuan Neipei (002448.SZ) has signed a strategic cooperation framework agreement with Ningbo Puzhi Future Robotics Co., Ltd. to collaborate on humanoid robot-related business [1] Group 1: Company Overview - Ningbo Puzhi Company is established by Junsheng Group's Ningbo Junpu Artificial Intelligence and Humanoid Robot Research Institute and its affiliate Shanghai Zhiyuan New Technology Co., Ltd. [1] - The company focuses on the application of general-purpose robots in smart manufacturing, with main business areas including robot body research and development, customized solutions for industrial scenarios, and innovation center operations [1] Group 2: Production Capacity - Ningbo Puzhi Company has an annual production capacity of 3,000 humanoid and wheeled robots, making it the first enterprise in Ningbo to achieve large-scale production in this field [1] Group 3: Strategic Development - The collaboration aims to develop specialized electric control actuators for humanoid robot joints, facilitating the transition of existing electric control system technology into the robotics sector [1] - This partnership is expected to optimize product performance by leveraging the partner's scenario resources, enabling the company to upgrade from an automotive parts supplier to a core component service provider in both "automotive + robotics" sectors, aligning with industry technological iteration trends [1]

每经AI快讯，中原内配（SZ 002448，收盘价：12.62元）12月19日晚间发布公告称，2025年12月19日， 中原内配集团股份有限公司控股子公司中原内配电子科技有限公司与宁波普智未来机器人有限公司签署 了《战略合作框架协议》，双方就人形机器人相关业务达成战略合作意向。 2025年1至6月份，中原内配的营业收入构成为：汽车零部件制造业占比88.67%，其他占比11.33%。 截至发稿，中原内配市值为74亿元。 每经头条（nbdtoutiao）——海南封关首日直击：为中国探路，全球最大自贸港如何重塑开放边界？ （记者 曾健辉） ...

Core Viewpoint - Zhongyuan Neipei (002448.SZ) has signed a strategic cooperation framework agreement with Ningbo Puzhi Future Robotics Co., Ltd. to collaborate on humanoid robot-related business [1] Group 1: Company Overview - Zhongyuan Neipei's subsidiary, Zhongyuan Neipei (Shanghai) Electronic Technology Co., Ltd., is involved in the strategic partnership with Ningbo Puzhi Company [1] - Ningbo Puzhi Company is established by Junsheng Group's Ningbo Junpu Artificial Intelligence and Humanoid Robotics Research Institute and its affiliate, Shanghai Zhiyuan New Technology Co., Ltd. [1] - Ningbo Puzhi Company focuses on the application of general-purpose robots in smart manufacturing, with main business areas including robot body research and development, customized solutions for industrial scenarios, and innovation center operations [1] Group 2: Production Capacity and Market Position - Ningbo Puzhi Company has an annual production capacity of 3,000 humanoid and wheeled robots, making it the first company in Ningbo to achieve large-scale production in this field [1] - The collaboration aims to develop specialized electric control actuators for humanoid robot joints, enhancing the existing electric control system technology for application in the robotics sector [1] Group 3: Strategic Implications - The partnership is expected to facilitate the transition from an automotive parts supplier to a core component service provider in both the "automotive + robotics" dual-track market, aligning with industry technology iteration trends [1]

Core Viewpoint - Zhongyuan Neipei (002448.SZ) has signed a strategic cooperation framework agreement with Ningbo Puzhi Future Robotics Co., Ltd. to collaborate on humanoid robot-related business [1] Group 1: Strategic Cooperation - The agreement establishes Ningbo Puzhi as the core supplier of joint modules for Zhongyuan's humanoid robots, ensuring product quality meets technical requirements and industry standards [1] - Specific details regarding product specifications, procurement quantities, unit prices, delivery cycles, acceptance standards, and payment methods will be outlined in separate sales or procurement contracts [1]

Core Viewpoint - The company has signed a strategic cooperation framework agreement with Ningbo Puzhi Future Robotics Co., Ltd., marking a significant step towards enhancing its capabilities in the humanoid robotics sector [1] Group 1: Partnership Details - The company's subsidiary, Zhongyuan Neipei (Shanghai) Electronic Technology Co., Ltd., will become the core supplier of humanoid robot joint modules for Ningbo Puzhi [1] - The agreement includes a five-year cooperation period starting from the date of signing [1] Group 2: Strategic Goals - The collaboration aims to promote technological commonality in the humanoid robotics field [1] - The partnership is intended to facilitate the company's transition from an automotive parts supplier to a core component service provider in both the automotive and robotics sectors [1]

证券代码：002448 证券简称：中原内配 公告编号：2025-046 中原内配集团股份有限公司 关于控股子公司签署战略合作框架协议的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、 误导性陈述或者重大遗漏。 特别提示 1、本次签署的合作协议为双方合作的框架性协议，履约过程中可能会出现 因双方经营计划、发展战略调整以及不可抗力等原因，导致变更、中止或终止， 具体实施内容和进度尚存在不确定性。后续合作与项目推进等具体事项尚需双方 进一步协商确定，具体合作内容以签订的具体项目合同为准。 2、本合作协议的签署预计对公司2025年度的财务状况和经营成果不构成重 大影响。公司将按照法律法规和《公司章程》的相关规定，对合作后续事项的落 地实施履行相应的审批程序和信息披露义务。敬请广大投资者谨慎决策，注意投 资风险。 一、本次框架协议签署概况 2025年12月19日，中原内配集团股份有限公司（以下简称"公司"）控股子 公司中原内配（上海）电子科技有限公司（以下简称"上海子公司"）与宁波普 智未来机器人有限公司（以下简称"宁波普智公司"）签署了《战略合作框架协 议》（以下简称"合作协议"），双方就人形 ...

Investment Summary - The automotive industry is benefiting from the acceleration of smart technology and the development of the robotics industry, with the parts sector outperforming the vehicle sector. From January 1 to December 12, 2025, the CITIC passenger car index fell by 0.40%, while the CITIC automotive parts index rose by 34.76%, indicating a significant difference in performance between the two sectors [4][18][25]. Group 1: 2025 Market Performance and Earnings Review - The automotive parts sector achieved a revenue of 7,541.60 billion yuan in the first three quarters of 2025, a year-on-year increase of 8.75%, and a net profit of 460.10 billion yuan, up 19.60% year-on-year [49]. - The passenger vehicle sector's revenue reached 15,203.16 billion yuan, growing by 8.68% year-on-year, while the net profit decreased by 15.72% to 391.90 billion yuan [31][49]. - The performance of passenger vehicle companies varied, with most showing revenue growth, but some, like BYD and Great Wall Motors, experienced profit declines [39][42]. Group 2: Outlook for 2026 - The automotive market in 2026 is expected to see a decline in policies, while exports and new energy vehicles (NEVs) will continue to rise. The "old-for-new" policy is anticipated to drive high growth in vehicle sales in 2025, but its absence in 2026 may lead to a demand shortfall [5][62][66]. - The penetration rate of NEVs is expected to continue increasing, with smart and high-end vehicles becoming new growth drivers. By 2025, the penetration rate of NEVs reached 46.7% [72][73]. - The L3 commercial application is expected to reach a critical point in 2026, with smart chassis technology anticipated to be applied in large quantities [5][6]. Group 3: Investment Strategy - The investment strategy focuses on the smart automotive sector, particularly as the industry transitions from L2 to L3 autonomous driving. Companies that continue to invest in this area are expected to benefit significantly [6][8]. - Recommended companies in the vehicle sector include SAIC Motor, Jianghuai Automobile, and Chery Automobile, which are positioned to leverage advancements in smart driving technology [6][8]. - In the parts sector, companies like Baolong Technology and Top Group are highlighted for their potential to benefit from the implementation of line control steering and braking systems, which are set to enter mass application in 2026 [8][49].